投稿咨詢
Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's.
Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:
Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results
Article Highlights – an executive summary of the author’s most critical points
《Expert Review Of Neurotherapeutics》是一本由TAYLOR & FRANCIS LTD出版商出版的專業醫學期刊，該刊創刊于2001年，刊期Monthly，該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 3區，小類學科：臨床神經病學 3區；藥學 3區；在JCR（Journal Citation Reports）分區等級為Q2。該刊發文范圍涵蓋臨床神經病學等領域，旨在及時、準確、全面地報道國內外臨床神經病學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為4.287，平均審稿速度偏慢,4-8周。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 醫學 | 3區 | CLINICAL NEUROLOGY 臨床神經病學 PHARMACOLOGY & PHARMACY 藥學 | 3區 3區 | 否 | 是 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q2 | CLINICAL NEUROLOGY | Q2 | 4.287 |
| PHARMACOLOGY & PHARMACY | Q2 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 4.287 | 63 | 7.82% | 19.78% | 未開放 | 偏慢,4-8周 |
課題、SCI/EI/SSCI怎么寫？